Prochlorperazine Edisylate
Who holds supplier records for Prochlorperazine Edisylate? 4 organisations hold a current record for Prochlorperazine Edisylate: an active US FDA Type II Drug Master File. A further 3 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (3) and Italy (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Prochlorperazine Edisylate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/prochlorperazine-edisylate
Reading the evidence
- 4 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
3 of the 4 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 2 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (4)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Prochlorperazine Edisylate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITEDIndiaActive DMF 32178 · latest filing Oct 2017
- Emcure Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 31176 · latest filing Dec 2016
- RAKS PHARMA PVT LTDIndiaActive DMF 33693 · latest filing Mar 2019
- TRIFARMA SPAItaly Company GMP cert on recordActive DMF 16055 · latest filing Jul 2002
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (3)
Organisations whose Type II DMFs for Prochlorperazine Edisylate are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- Inactive DMF 10213 · filed Apr 1993
- United States · Inactive DMF 5425 · filed Jan 1984
- France · Inactive DMF 3545 · filed May 1979
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Prochlorperazine Edisylate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201154).
Chemical identity
- IUPAC name
- 2-chloro-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine;ethane-1,2-disulfonic acid
- Canonical SMILES
- CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl.C(CS(=O)(=O)O)S(=O)(=O)O
- InChIKey
- SWOUGRBFXFILIB-UHFFFAOYSA-N
- Synonyms
- Compazine, NSC-757299, Prochlorperazine edisilate, Prochlorperazine edisylate, Prochlorperazine edisylate salt, prochlorperazine ethanedisulfonate, Prochlorperazine edisylate (USP), Prochlorperazine edisylate [USP], NSC665801, RefChem:55922, Prochlorperazine Edisylate, USP, Prochlorperazine ethane disulfonate
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Phenothiazine
- Chemical structure
- Phenothiazines
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Prochlorperazine Edisylate?
4 organisations hold an active US FDA Type II Drug Master File or a CEP for Prochlorperazine Edisylate: BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), Emcure Pharmaceuticals Limited (India), RAKS PHARMA PVT LTD (India) and TRIFARMA SPA (Italy). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Prochlorperazine Edisylate Drug Master Files are active?
BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 32178), Emcure Pharmaceuticals Limited (DMF 31176), RAKS PHARMA PVT LTD (DMF 33693) and TRIFARMA SPA (DMF 16055). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Prochlorperazine Edisylate records mean?
3 organisations have only inactive Type II DMFs for Prochlorperazine Edisylate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Prochlorperazine Edisylate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Prochlorperazine Edisylate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.